A Trial of Tisotumab Vedotin in Japanese Subjects With Advanced Solid Malignancies
Clinical trial NCT03913741 · COMPLETED
Trial details
- NCT number
- NCT03913741
- Sponsor
- Genmab
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-27
- Primary completion
- 2020-08-14
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.